Activity Downloads

To Participate

To participate in this continuing education activity:

1. Review the activity description and objectives.
2. View the activity.
3. Complete the online post-test and activity evaluation.

Free for SIDP and ACCP ID PRN Members*
 Click here to enter the code►

Enter the code provided by your member group to participate in this activity at no cost. Login to the CE Center and redeem your enrollment code using the box on our home screen.
*Membership in SIDP or ACCP ID PRN must be active. If membership is not active, the participant is responsible for renewing membership or purchasing the CE activity. 

 

NOTE: If you attended this CE activity live (via webinar) on September 21, 2021, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-21-249-L01-P, or Laboratory PACE credit), you are NOT allowed to also receive CE credit for this home-study activity.

Description

Join us for this annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast will include recent CLSI antimicrobial susceptibility testing updates. We will discuss ways to incorporate these changes in your antimicrobial stewardship efforts and collaboration opportunities with stewardship and the microbiology laboratory.

Learning Objectives

The target audience for this activity is pharmacists and Laboratory Professionals. At the completion of this activity, the participant will be able to:

• Discuss updates to the 2021 CLSI standards for antimicrobial susceptibility testing and reporting.
• Describe use of rapid methods for microbial identification and susceptibility testing.
• Identify opportunities for collaboration between stewardship and the microbiology laboratory.

Faculty

April Abbott, Ph.D., D(ABMM)
Director, Microbiology and Molecular Diagnostics
Deaconess Health System
Adjunct Assistant Professor
Microbiology and Immunology
Indiana University School of Medicine
Evansville, Indiana

Sasha Premraj, PharmD, BCPS, BCIDP
Infectious Diseases Clinical Pharmacy Specialist
Sacred Heart Hospital
Ascension
Pensacola, Florida

Accreditation

Release Date: September 21, 2021
Expiration Date: September 21, 2024

Pharmacists

This CE activity is jointly provided by ProCE, LLC, CLSI, and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-249-H01-P has been assigned to this knowledge-based home-study CE activity. This CE activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

PACE

Clinical and Laboratory Standards Institute is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^â Program.

Disclosure

It is the policy of ProCE, LLC to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Sasha Premraj has no relevant commercial and/or financial relationships to disclose. April Abbott has no relevant commercial and/or financial relationships to disclose.

Funding

This activity is self-funded by SIDP, CLSI, and members of ACCP ID PRN.

 

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.